Trillium Therapeutics logo

Trillium Therapeutics

Trillium Therapeutics is a biotechnology company developing cancer immunotherapies.

2

Funding Rounds

$26.0m

Money raised

Overview

Trillium Therapeutics is a biotechnology company developing cancer immunotherapies.

Funding series

Funding Series Analysis

The company Trillium Therapeutics has raised a total of $1m in funding over 2 rounds.

Key Insights:

  • Trillium Therapeutics funding round, May 2011: $1m
  • Trillium Therapeutics Venture round, September 2020: $25m
Trillium Therapeutics logo
Trillium Therapeutics funding round, May 2011 $1m
Trillium Therapeutics logo
Trillium Therapeutics Venture round, September 2020 $25m